Glide(US) | $15,000,000 | (May 9, 2025)
Kouper | $10,000,000 | (May 9, 2025)
Doubleword (prev. TitanML) | $12,000,000 | (May 9, 2025)
Certified by Founder
Lodge
Odyssey Therapeutics
start up
United States
- Boston, Massachusetts
- 06/12/2023
- Series C
- $101,000,000
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
- Industry Biotechnology Research
- Website https://www.odysseytx.com/
- LinkedIn https://www.linkedin.com/company/odyssey-tx/about/
VESTIGAS | $9,003,240 | (May 9, 2025)
HAYA Therapeutics | $65,000,000 | (May 9, 2025)
Una Software | $4,400,000 | (May 9, 2025)
Zebu Intelligent Systems Pvt Ltd | $1,000,000 | (May 9, 2025)
Jozu | $4,000,000 | (May 9, 2025)
PATH EX, Inc. | $5,000,000 | (May 9, 2025)
Blank Beauty | Undisclosed Amount | (May 9, 2025)
Pulse Charter Connect | $2,000,000 | (May 9, 2025)
CodeAnt AI (YC W24) | $2,000,000 | (May 8, 2025)